Literature DB >> 21793178

Red blood cell transfusion in pediatric patients with severe chronic anemia: how slow is necessary?

Anurag K Agrawal1, Edmund Hsu, Keith Quirolo, Lynne D Neumayr, Heidi R Flori.   

Abstract

Historic practice recommends slow transfusion for children with chronic anemia and hemoglobin less than 5.0 g/dl due to the theoretical risk of transfusion-associated circulatory overload (TACO). In our pediatric intensive care unit (PICU), we have been utilizing a more liberal transfusion practice in patients without underlying cardiopulmonary disease, and a faster transfusion rate appears safe in this population. Rate of transfusion must be based on multiple factors including convenience, timeliness of procedures and transport to an appropriate care facility, risk of alloimmunization and wastage of blood, stress for the family, and need for PICU monitoring.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21793178     DOI: 10.1002/pbc.23238

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

1.  Differential effects of speed and volume on transfusion-associated circulatory overload: A randomized study in rats.

Authors:  Robert B Klanderman; Marije Wijnberge; Joachim J Bosboom; Joris J T H Roelofs; Dirk de Korte; Robin van Bruggen; Markus W Hollmann; Margreeth B Vroom; Denise P Veelo; Nicole P Juffermans; Bart F Geerts; Alexander P J Vlaar
Journal:  Vox Sang       Date:  2021-08-15       Impact factor: 2.996

2.  Effects of non-leukocyte-reduced and leukocyte-reduced packed red blood cell transfusions on oxygenation of rat spinotrapezius muscle.

Authors:  Sripriya Sundararajan; Sami C Dodhy; Roland N Pittman; Stephen J Lewis
Journal:  Microvasc Res       Date:  2013-11-02       Impact factor: 3.514

3.  Volume incompliance and transfusion are essential for transfusion-associated circulatory overload: a novel animal model.

Authors:  Robert B Klanderman; Joachim J Bosboom; Adrie A W Maas; Joris J T H Roelofs; Dirk de Korte; Robin van Bruggen; Jaap D van Buul; Coert J Zuurbier; Denise P Veelo; Markus W Hollmann; Margreeth B Vroom; Nicole P Juffermans; Bart F Geerts; Alexander P J Vlaar
Journal:  Transfusion       Date:  2019-11-07       Impact factor: 3.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.